FBXO32 and Atrophy: Additionally, IFN‐I exposure has been shown to cause muscle atrophy, accompanied by the upregulation of atrophy‐related genes, such as Atrogin‐1 and Murf‐1, suggesting that muscle atrophy in DM patients may be linked to the activation of the IFN‐I pathway.